Application of Bld-1-Embedded Elastin-Like Polypeptides in Tumor Targeting

Area of Science:

• Biotechnology
• Nanomedicine
• Oncology

Background:

• Cancer cells express unique surface molecules enabling targeted therapy.
• Targeted drug delivery systems can improve efficacy and reduce side effects.
• Peptide-modified polymers offer a platform for selective drug delivery.

Purpose of the Study:

• To synthesize and evaluate a novel tumor targeting system for bladder cancer therapy.
• To utilize the Bld-1 peptide and a thermally responsive polypeptide (ELP) for targeted drug delivery.
• To assess the specificity and efficacy of the Bld-1 peptide-ELP conjugate (B5V60) in targeting sialyl-Tn antigen.

Main Methods:

• Synthesis of B5V60, a conjugate of five Bld-1 peptides and ELP77.
• Analysis of bioactivities and binding capabilities of B5V60 to bladder tumor cells.
• In vivo studies using bladder tumor xenograft mice to evaluate B5V60 localization.

Main Results:

• B5V60 demonstrated superior binding to bladder tumor cells.
• Cellular accumulation of B5V60 correlated with sialyl-Tn antigen (STn) expression.
• B5V60 showed excellent tumor localization in vivo, confined to STn-overexpressing tissues.

Conclusions:

• The novel B5V60 system exhibits high potential for STn-specific targeted cancer therapy.
• B5V60 can serve as a carrier for selective drug delivery to bladder tumors.
• This targeted approach holds promise for improved cancer treatment outcomes.